CureMetrix is committed to the advancement of technology that improves disease detection and survival rates worldwide. Leveraging the power of Artificial Intelligence (AI), CureMetrix develops the next generation of medical image analysis technology focused on mammography to empower radiologists with objective, data-driven answers for better patient care.

Since its founding in 2014, CureMetrix has partnered with practicing radiologists, cardiologists, and esteemed institutions globally, utilizing over 5 million images to train and validate AI algorithms aimed at improving outcomes in breast cancer, heart disease, and kidney disease screening programs.

The mission of CureMetrix is to save lives and support better clinical and financial outcomes by delivering powerful AI-based tools that improve early and more accurate disease detection, reduce healthcare costs, enhance clinical workflow efficiency, and increase assurance in women’s health screening.

The company's key focus areas include reducing recall rates, increasing early detection, improving evaluation of dense breast tissue, tracking treatment response over time, and improving clinical efficiency through innovative AI solutions.

CureMetrix is headquartered at 402 West Broadway, Suite 400, San Diego, CA 92101, United States.

For questions and support, they can be contacted at 858-333-5830.

Follow CureMetrix on LinkedIn for latest updates and job postings: https://www.linkedin.com/company/curemetrix/